Rankings
▼
Calendar
EYPT FY 2019 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$20M
+587.8% YoY
Gross Profit
$18M
86.8% margin
Operating Income
-$48M
-235.0% margin
Net Income
-$57M
-278.9% margin
EPS (Diluted)
$-6.04
Cash Flow
Operating Cash Flow
-$57M
Free Cash Flow
-$57M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$73M
Total Liabilities
$65M
Stockholders' Equity
$8M
Cash & Equivalents
$22M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20M
$3M
+587.8%
Gross Profit
$18M
-$16M
+213.8%
Operating Income
-$48M
-$26M
-82.2%
Net Income
-$57M
-$53M
-6.8%
← Q4 2018
All Quarters
Q1 2019 →